Patents Assigned to INNOCOLL PHARMACEUTICALS LIMITED
  • Patent number: 11746141
    Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: September 5, 2023
    Assignee: INNOCOLL PHARMACEUTICALS LIMITED
    Inventors: Alexandra Dietrich, Michael Myers
  • Patent number: 11623947
    Abstract: There is a need to provide a collagen powder having desirable product characteristics, such as high fluid absorption capacity, while also having processing characteristics that allow commercial manufacturing and handling of the collagen powder. The present invention relates to a collagen powder, a method of manufacture thereof, and uses thereof. In particular, the present invention relates to a process for preparing a collagen powder, the process comprising the steps of providing a collagen source; adjusting the concentration of the collagen source; adjusting the pH of the collagen source; freezing the collagen source; dehydrating the frozen collagen; and degrading the dehydrated collagen to a powder.
    Type: Grant
    Filed: April 8, 2013
    Date of Patent: April 11, 2023
    Assignee: Innocoll Pharmaceuticals Limited
    Inventors: Alexandra Dietrich, Michael Myers, Stefan Schneid
  • Publication number: 20220281953
    Abstract: There is a need to provide a collagen powder having desirable product characteristics, such as high fluid absorption capacity, while also having processing characteristics that allow commercial manufacturing and handling of the collagen powder. The present invention relates to a collagen powder, a method of manufacture thereof, and uses thereof. In particular, the present invention relates to a process for preparing a collagen powder, the process comprising the steps of providing a collagen source; adjusting the concentration of the collagen source; adjusting the pH of the collagen source; freezing the collagen source; dehydrating the frozen collagen; and degrading the dehydrated collagen to a powder.
    Type: Application
    Filed: October 18, 2021
    Publication date: September 8, 2022
    Applicant: INNOCOLL PHARMACEUTICALS LIMITED
    Inventors: Alexandra DIETRICH, Michael Myers, Stefan Schneid
  • Publication number: 20220213173
    Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Applicant: INNOCOLL PHARMACEUTICALS LIMITED
    Inventors: Alexandra DIETRICH, Michael Myers
  • Publication number: 20190359689
    Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.
    Type: Application
    Filed: August 9, 2019
    Publication date: November 28, 2019
    Applicant: INNOCOLL PHARMACEUTICALS LIMITED
    Inventors: Alexandra DIETRICH, Michael Myers
  • Patent number: 10487134
    Abstract: The present invention relates to a modified collagen obtainable by providing isolated collagen; freezing the isolated collagen; dehydrating the frozen collagen; and maturing the dehydrated collagen. Also disclosed are methods of preparing the modified collagen and uses thereof.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: November 26, 2019
    Assignee: INNOCOLL PHARMACEUTICALS LIMITED
    Inventors: Alexandra Dietrich, Michael Myers
  • Patent number: RE47826
    Abstract: The invention relates to a drug delivery device for providing local analgesia, local anesthesia or nerve blockade at a site in a human or animal in need thereof, the device comprising a fibrillar collagen matrix; and at least one drug substance selected from the group consisting of amino amide anesthetics, amino ester anesthetics and mixtures thereof, the at least one drug substance being substantially homogeneously dispersed in the collagen matrix, and the at least one drug substance being present in an amount sufficient to provide a duration of local analgesia, local anesthesia or nerve blockade which lasts for at least about one day after administration.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: January 28, 2020
    Assignee: INNOCOLL PHARMACEUTICALS LIMITED
    Inventors: Michael Myers, Philip Wallace Reginald